Hildreth, Andrew D. http://orcid.org/0000-0001-8447-4817
Padilla, Eddie T. http://orcid.org/0000-0001-8230-8719
Gupta, Meha http://orcid.org/0009-0004-1556-5722
Wong, Yung Yu
Sun, Ryan
Legala, Akshara R. http://orcid.org/0000-0001-7012-7152
O’Sullivan, Timothy E. http://orcid.org/0000-0003-1435-8188
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F31DK130585)
Article History
Received: 31 October 2022
Accepted: 18 October 2023
First Online: 23 November 2023
Competing interests
: T.E.O. is an advisory board member for Modulus Therapeutics and Xyphos Inc. The other authors declare no competing interests.